Public Firm Embraces Altcoins for Strategic Gains


In an intriguing move, 180 Life Sciences, a publicly traded company in the United States, is set to enhance its market position by building an Ethereum (ETH) reserve. This initiative mirrors the successful strategy employed by MicroStrategy, highlighting a potential uptick in the cryptocurrency sector.

Continue Reading:Public Firm Embraces Altcoins for Strategic Gains

Source: https://en.bitcoinhaber.net/public-firm-embraces-altcoins-for-strategic-gains